Integrated Diagnostics Receives $30,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Integrated Diagnostics
  • Mailing Address
    1441 N. 34th Street Seattle, WA 98103
  • Company Description
    The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer’s through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins. The company will be developing diagnostic tools to help patients and physicians detect disease in its earliest stages.
  • M&A Terms
  • Venture Investor
    InterWest Partners
  • Venture Investor
    The Wellcome Trust
  • Venture Investor
    Dievini Hopp Biotech Holding

Trending on Xconomy